{"url_path":"/sec/jagx/8-k/2026-06-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-253506-index.html","accession_number":"0001193125-26-253506","cik":"0001585608","ticker":"JAGX","issuer_name":"Jaguar Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-253506-index.html","primary_entity_key":"0001585608","primary_entity_name":"Jaguar Health, Inc."},"word_count":90,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNo.\n\n  \nDescription\n\n10.1\n  \n[Streeterville Exchange Agreement, dated May 26, 2026](d95782dex101.htm)\n\n10.2\n  \n[Streeterville Exchange Agreement, dated June 1, 2026](d95782dex102.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nJAGUAR HEALTH, INC.\n\nDate: June 2, 2026\n \n\n \nBy:\n \n\n/s/ Lisa A. Conte\n\n \n\n \n\n \n\nLisa A. Conte\n\nChief Executive Officer & President"}